Showing results (121-130 of 279) with videos related to

Sort By:
Pageof 28
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 15, 2006
C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in womenEsther K Wei, Jing Ma, Michael N Pollak, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2010
Plasma levels of acid-labile subunit, free insulin-like growth factor-I, and prostate cancer risk: a prospective studyLorelei A Mucci, Jennifer R Stark, Michael N Pollak, et al.
Journal of Orthopaedic Trauma|May 24, 2014
Current bacterial speciation and antibiotic resistance in deep infections after operative fixation of fracturesJesse T Torbert, Manjari Joshi, Adrienne Moraff, et al.
Breast Cancer Research and Treatment|October 23, 2012
Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses' Health StudiesMegan S Rice, Shelley S Tworoger, Bernard A Rosner, et al.
The Journal of Arthroplasty|June 21, 2020
The Affordable Care Act and Global Budget Revenue: The Impact on Total Hip ArthroplastiesRonald E Delanois, Wayne A Wilkie, Nequesha S Mohamed, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 29, 1999
Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged menE A Platz, M N Pollak, E B Rimm, et al.
Journal of the National Cancer Institute|April 15, 1999
Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3J Ma, M N Pollak, E Giovannucci, et al.
International Journal of Cancer|May 18, 2010
Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer in the Health Professionals Follow-up Study 1993-2004Katharina Nimptsch, Elizabeth A Platz, Michael N Pollak, et al.
Gynecologic Oncology|August 25, 2009
BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamideMarie-Claude Beauchamp, Ariane Knafo, Amber Yasmeen, et al.
Pageof 28